Verwandte Artikel zu Biomarker Methods in Drug Discovery and Development...
Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology) - Softcover
Inhaltsangabe
In this book, expert researchers provide a tool box for those who have a general interest in biomarker research and for those currently specializing in certain technologies but desiring an understanding of other available methodologies. Its chapters include validated, mature methods as well as new, incredibly promising protocols which aim to apply multiple technologies at different molecular levels in order to surmount the monumental and complex task of transforming the pharmaceutical research and development processes. As a volume in the Methods in Pharmacology and Toxicology™ series, this book offers user-friendly, step-by-step laboratory protocols for readily reproducible experiments. Comprehensive and state-of-the-art, this is the perfect biomarker technical guideline and reference to stimulate more exciting biomarker research and technology development.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Von der hinteren Coverseite
Within the pharmaceutical industry, the improvement of drug discovery and development efficiency and the expected personalization of medicine have become vitally important issues. In Biomarker Methods in Drug Discovery and Development, expert researchers provide a tool box for those who have a general interest in biomarker research and for those currently specializing in certain technologies but desiring an understanding of other available methodologies. Its chapters include validated, mature methods as well as new, incredibly promising protocols which aim to apply multiple technologies at different molecular levels in order to surmount the monumental and complex task of transforming the pharmaceutical research and development processes. As a volume in the Methods in Pharmacology and Toxicology series, this book offers user-friendly, step-by-step laboratory protocols for readily reproducible experiments.
Comprehensive and state-of-the-art, Biomarker Methods in Drug Discovery and Development is the perfect biomarker technical guideline and reference to stimulate more exciting biomarker research and technology development.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Neu kaufen
Diesen Artikel anzeigen
EUR 158,07
EUR 3,42 für den Versand innerhalb von/der USA
Versandziele, Kosten & Dauer
Suchergebnisse für Biomarker Methods in Drug Discovery and Development...
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology)
Anbieter: Lucky's Textbooks, Dallas, TX, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar2811580148659
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Biomarker Methods in Drug Discovery and Development
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers 12063940-n
Anzahl: 15 verfügbar
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development (Paperback)
Verlag:
Humana Press Inc., Totowa, NJ, 2010
ISBN 10: 1617379255
ISBN 13: 9781617379253
Neu
Paperback
Erstausgabe
Anbieter: Grand Eagle Retail, Mason, OH, USA
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: new. Paperback. The pharmaceutical industry has faced many significant challenges since the early 1990s. The fundamental issue that needs to be addressed is how to improve the efficiency of drug discovery and development. The current research and development (R&D) cost for developing a new therapeutic drug is greater than $800 million. Additionally, it takes an average of 12 years to get a new drug to market with an attrition rate greater than 90%. Reviewing the overall pharmaceutical R&D process, it has become clear that many of the drug failures are due to our lack of knowledge in population diversity, which is responsible for differences in drug efficacy and toxicity. In fact, not a single approved drug is 100% safe and efficacious for all patients. For researchers, the key question is: How can we discover biomarkers that can be used to distinguish patients who will respond to the drug without adverse effects from those who will not respond and/or will have adverse effects? There is tremendous urgency to address this question. Biomarkers also fit perfectly with the vision of personalized medicine, the new expectation of medical practice. This is why biomarker research has been a central focus in many research labs across academia, government agencies, and the pharmaceutical industry. There are many different ways to define biomarkers based on molecular properties, applications, and methods. Reviewing the overall pharmaceutical R&D process, it has become clear that many of the drug failures are due to our lack of knowledge in population diversity, which is responsible for differences in drug efficacy and toxicity. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9781617379253
Anzahl: 1 verfügbar
Foto des Verkäufers
Biomarker Methods in Drug Discovery and Development
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 12063940
Anzahl: 15 verfügbar
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology)
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. In. Bestandsnummer des Verkäufers ria9781617379253_new
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development
Anbieter: Books Puddle, New York, NY, USA
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. pp. 424. Bestandsnummer des Verkäufers 263101084
Anzahl: 4 verfügbar
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development
Print-on-DemandAnbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Print on Demand pp. 424 88 Illus. (9 Col.). Bestandsnummer des Verkäufers 5828163
Anzahl: 4 verfügbar
Foto des Verkäufers
Biomarker Methods in Drug Discovery and Development
Print-on-DemandAnbieter: moluna, Greven, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Broad coverage of proven and practical biomarker techniques currently applied in drug discovery and development Multiple biomarker analysis methods for each of the different molecular levels Real biomarker applications from early discovery . Bestandsnummer des Verkäufers 458521773
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development
Print-on-DemandAnbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. PRINT ON DEMAND pp. 424. Bestandsnummer des Verkäufers 183101078
Anzahl: 4 verfügbar
Beispielbild für diese ISBN
Biomarker Methods in Drug Discovery and Development (Paperback)
Verlag:
Humana Press Inc., Totowa, NJ, 2010
ISBN 10: 1617379255
ISBN 13: 9781617379253
Neu
Paperback
Erstausgabe
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: new. Paperback. The pharmaceutical industry has faced many significant challenges since the early 1990s. The fundamental issue that needs to be addressed is how to improve the efficiency of drug discovery and development. The current research and development (R&D) cost for developing a new therapeutic drug is greater than $800 million. Additionally, it takes an average of 12 years to get a new drug to market with an attrition rate greater than 90%. Reviewing the overall pharmaceutical R&D process, it has become clear that many of the drug failures are due to our lack of knowledge in population diversity, which is responsible for differences in drug efficacy and toxicity. In fact, not a single approved drug is 100% safe and efficacious for all patients. For researchers, the key question is: How can we discover biomarkers that can be used to distinguish patients who will respond to the drug without adverse effects from those who will not respond and/or will have adverse effects? There is tremendous urgency to address this question. Biomarkers also fit perfectly with the vision of personalized medicine, the new expectation of medical practice. This is why biomarker research has been a central focus in many research labs across academia, government agencies, and the pharmaceutical industry. There are many different ways to define biomarkers based on molecular properties, applications, and methods. Reviewing the overall pharmaceutical R&D process, it has become clear that many of the drug failures are due to our lack of knowledge in population diversity, which is responsible for differences in drug efficacy and toxicity. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Bestandsnummer des Verkäufers 9781617379253
Anzahl: 1 verfügbar